Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Rheumatologist
MBBS, FCPS (Medicine), FCPS ( Rheumatology), CHPE , FRCP, CHPE
Internal Medicine Specialist
B.Sc, M.B.B.S., Certification in Diabetes , F.C.P.S (Medicine), MACP (USA), Fellow of Gastroenterology, MRCP 1 & 2 UK, MACG(USA)
Internal Medicine Specialist
B.Sc, M.B.B.S., Certification in Diabetes , F.C.P.S (Medicine), MACP (USA), Fellow of Gastroenterology, MRCP 1 & 2 UK, MACG(USA)
Diabetologist
MBBS, FCPS (Medicine), Fellowship in Endocrinology
Consultant Physician
M.B.B.S., M.D.
Internal Medicine Specialist
F.C.P.S. (Medicine), M.D (Gastroentology)
Gastroenterologist
M.B.B.S, F.C.P.S (Gastroenterology)
Diabetologist
M.B.B.S, F.C.P.S. (Medicine) , MD (USA)
Endocrinologist
M.B.B.S., F.C.P.S. (Medicine), F.C.P.S. (Endocrinologist)
Internal Medicine Specialist
M.B.B.S., F.C.P.S (Medicine)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures